Orchid Pharma Board Meeting Date

PartnershipAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Orchid Pharma Partnership

Orchid Pharma entered a licensing and supply agreement with Laboratorio Libra for Exblifep across nine Latin American markets. The partnership is expected to represent a potential opportunity of about USD 80 million over 10 years.

Fund RaiseAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Orchid Pharma Fund Raise of ₹600 Cr

Orchid Pharma's board approved an enabling resolution to raise funds of up to ₹600 Crore through equity or debt securities via various permissible modes.

Value

₹600.0 Cr

Other Announcement

Orchid Pharma Other Announcement

The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.

Board Meeting Date

Orchid Pharma Board Meeting Date

Orchid Pharma has scheduled a board meeting for October 20, 2026, to consider options for raising funds. The company will explore various suitable funding avenues.

Other Announcement

Orchid Pharma Other Announcement

Orchid Pharma Ltd has filed its quarterly Shareholding Pattern, providing a routine update on promoter and public shareholding as mandated by SEBI regulations.

Annual General Meeting

Orchid Pharma Annual General Meeting

Orchid Pharma held its 33rd Annual General Meeting on September 29, 2026, where shareholders considered and approved routine business resolutions and related party transactions.

Board Meeting DateMehta Securities Ltd MEHSECU

Mehta Securities Board Meeting Date

Mehta Securities has scheduled a board meeting on 6 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.

Board Meeting DateMehta Integrated Finance Ltd MEHIF

Mehta Integrated Finance Board Meeting Date

Mehta Integrated Finance scheduled a board meeting on November 6, 2026 to approve half-year results. The trading window remains closed until results are declared.

Board Meeting DateSanjivani Paranteral Ltd SANJIVIN

Sanjivani Paranteral Board Meeting Date

Sanjivani Paranteral will hold a board meeting on 5 November 2026 to approve Q2 unaudited results. The agenda is only proposed until the meeting is held.

Board Meeting DateKalpataru Projects International Ltd KPIL

Kalpataru Projects International Board Meeting Date

Kalpataru Projects will hold a board meeting on November 5, 2026 to approve quarterly and half-year results. An investor call follows on November 6, and the trading window stays closed.

Board Meeting DateNACDAC Infrastructure Ltd 544313

NACDAC Infrastructure Board Meeting Date

NACDAC Infrastructure will hold a board meeting on November 4, 2026 to approve unaudited standalone half-year results ended September 30, 2026. Trading window remains closed until 48 hours after declaration.

Board Meeting DateDeep Health AI India Ltd DDIL

Deep Health AI India Board Meeting Date

Deep Health AI will hold a board meeting on 3 November 2026 for unaudited quarterly and half-year results. Trading window stays closed until 48 hours after results.